Loading...
Loading...
VTRS| Name | Value |
|---|---|
| Revenues | 3,663.4M |
| Cost of Revenue | 2,159.4M |
| Gross Profit | 1,504.0M |
| Operating Expense | 1,217.2M |
| Operating I/L | 203.9M |
| Other Income/Expense | 0.7M |
| Interest Income | 0.0M |
| Pretax | 204.6M |
| Income Tax Expense | 90.7M |
| Net Income/Loss | 113.9M |
Viatris Inc. is a global healthcare company that operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers a wide range of prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs) across various therapeutic areas. It distributes its products through pharmaceutical wholesalers/distributors, retailers, pharmacies, and specialty pharmacies. Viatris generates revenue by selling its medicines in various forms, including oral solid doses, injectables, and complex dosage forms, as well as APIs, to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions.
